Passion Innovation Group

prostaCare

prostaCare develops prostaFix, a new, very gentle therapy to fix prostate enlargement. prostaFix is based on a soft-flow direct current based technology and therefore has much less side effects than current treatments – no Erectile Dysfunction, no Incontinence, no pain. Post a successful proof of concept, prostaFix is now in its final development phase including CE mark and regulatory trials. Once prostaFix is launched, physicians will be able to fix prostate enlargement in less than an hour in their practice and patients will be able to go back to their daily routine without the need for a hospital stay.